Expected mistakes, the need for speed, and change to come: CBER's Peter Marks looks ahead
In a wide-ranging Nov. 6 discussion with the president and CEO of the Friends of Cancer Research, Jeff Allen, CBER director Marks spoke to tempering public expectation, sustaining CBER staff despite a crushing workload during the coronavirus pandemic, and the possibility of more changes in 2021.
Under a new administration, said Marks, speaking at a virtual session of BioPharma Congress 2020, much could change. “So my hope is that we’ve already started the foundation for what needs to happen here.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.